Health Canada approves drug to slow Alzheimer’s disease – Dr Ducharme

Published on: 2025-11-28 08:00

Health Canada has just approved lecanemab, a drug already authorised in several other countries for the treatment of Alzheimer’s disease. This treatment could delay the onset of symptoms by about a year in people at risk.

In a television report on Le Téléjournal (Radio-Canada), Dr Ducharme shares his expertise on this new treatment and its implications for patients. partage son son expertise sur ce nouveau traitement et ses implications pour les patients.

For more information, see also the article published in La Presse:

Health Canada approves drug to slow Alzheimer’s disease – Dr Ducharme

Source: Radio Canada